Tumor necrosis factor-a is an endogenous inhibitor of Na+-K+-2CI- cotransporter (NKCC2) isoform A in the thick ascending limb
Pharmacological manipulation of arachidonic acid-epoxygenase results in divergent effects on renal damage
Vena cava and aortic smooth muscle cells express transglutaminases 1 and 4 in addition to transglutaminase 2
